Market Indices


Latest News

Craig-Hallum analyst issues BUY recommendation for CTRN on March 18,...

March 18, 2026   CTRN -2.57%

Craig-Hallum analyst issues BUY recommendation for SCOR on March 18,...

March 18, 2026   SCOR 1.67%

Jefferies analyst issues BUY recommendation for CTMX on March 18,...

March 18, 2026   CTMX -12.57%

Raymond James analyst issues STRONG BUY recommendation for ELVA on...

March 18, 2026   ELVA -3.62%

Assembly Biosciences, Inc. (ASMB) confirmed earnings release on March 19, 2026,...

March 18, 2026   ASMB -2.10%


Price Targets

Stephen Willey from Stifel Nicolaus issued a price target of $17.00 for ABEO on 2026-03-17 19:53:00.The adjusted price target was set to $17.00.At the time of the announcement,

March 17, 2026   ABEO -2.84%

Michael Baker from D.A. Davidson issued a price target of $68.00 for CTRN on 2026-03-17 19:35:00.The adjusted price target was set to $68.00.At the time of the announcement,

March 17, 2026   CTRN -2.57%

Aaron Spychalla from Craig-Hallum issued a price target of $19.00 for BW on 2026-03-17 13:54:00.The adjusted price target was set to $19.00.At the time of the announcement, BW...

March 17, 2026   BW -4.83%

Greg Renza from Truist Financial issued a price target of $12.00 for CATX on 2026-03-17 12:35:00.The adjusted price target was set to $12.00.At the time of the announcement,

March 17, 2026   CATX -0.20%

Matthew Biegler from Oppenheimer issued a price target of $12.00 for CTMX on 2026-03-16 13:30:00.The adjusted price target was set to $12.00.At the time of the announcement, CTMX...

March 16, 2026   CTMX -12.57%



Market Movers

Top Gainers (%)
ARBEW
Arbe Robotics Ltd. Warran
0.08
29.45%
WGSWW
WGSWW
0.01
25.21%
CSTE
Caesarstone Ltd.
0.78
19.37%
ORGNW
Origin Materials Inc Warr
0.00
18.42%
TLYS
Tilly's, Inc.
3.39
17.13%
AXTI
AXT, Inc.
50.55
13.95%
ALDX
Aldeyra Therapeutics, Inc
1.41
13.71%
OVID
Ovid Therapeutics Inc.
2.27
12.94%

Annual/Quarterly Reports Summary

In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...

November 6, 2024   AIP 2.17%

In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...

November 6, 2024   EOSEW -34.96%

In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...

November 6, 2024   EOSE -2.75%

In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...

November 5, 2024   STOK -3.87%

In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...

November 5, 2024   BSVN -1.17%